Remove 2030 Remove Drug Development Remove EHR
article thumbnail

How to Leverage DTx with Your Digital Health Strategy | Part 1 of 2

Xealth

billion by 2030. Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drug development life cycles. Xealth specializes in centralizing all your digital assets and programs within your EHR through a single integration.

article thumbnail

Digital Health v HealthTech: What is the difference?

Lloyd Price

Examples include electronic health records (EHRs), clinical decision support systems, and population health management systems. HealthTech 2030: Trends that are likely to shape the future of healthtech The landscape of healthcare is undergoing a dramatic transformation, driven by rapid advancements in technology.